Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:7805058.
doi: 10.1155/2017/7805058. Epub 2017 Mar 19.

Epigenetic Regulations in Diabetic Nephropathy

Zeyuan Lu  1 , Na Liu  2 , Feng Wang  1
Affiliations
Review

Epigenetic Regulations in Diabetic Nephropathy

Zeyuan Lu et al. J Diabetes Res. 2017.

Abstract

Diabetic nephropathy (DN) is a chronic complication of diabetes and the most common cause of end-stage kidney disease. It has been reported that multiple factors are involved in the pathogenesis of DN, while the molecular mechanisms that lead to DN are still not fully understood. Numerous risk factors for the development of diabetic nephropathy have been proposed, including ethnicity and inherited genetic differences. Recently, with the development of high-throughput technologies, there is emerging evidence that suggests the important role of epigenetic mechanisms in the pathogenesis of DN. Epigenetic regulations, including DNA methylation, noncoding RNAs, and histone modifications, play a pivotal role in DN pathogenesis by a second layer of gene regulation. All these findings can contribute to developing novel therapies for DN.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Jones C. A., Krolewski A. S., Rogus J., Xue J. L., Collins A., Warram J. H. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney International. 2005;67(5):1684–1691. doi: 10.1111/j.1523-1755.2005.00265.x. - DOI - PubMed
    1. Thomas M. C., Brownlee M., Susztak K., et al. Diabetic kidney disease. Nature Reviews Disease Primers. 2015;1 doi: 10.1038/nrdp.2015.18.15018 - DOI - PMC - PubMed
    1. Regele F., Jelencsics K., Shiffman D., et al. Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes. Nephrology Dialysis Transplantation. 2015;30(s4):iv26–iv34. doi: 10.1093/ndt/gfv087. - DOI - PubMed
    1. Cowie C. C., Port F. K., Wolfe R. A., Savage P. J., Moll P. P., Hawthorne V. M. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. New England Journal of Medicine. 1989;321(16):1074–1079. doi: 10.1056/NEJM198910193211603. - DOI - PubMed
    1. Pirola L., Balcerczyk A., Okabe J., El-Osta A. Epigenetic phenomena linked to diabetic complications. Nature Reviews Endocrinology. 2010;6(12):665–675. doi: 10.1038/nrendo.2010.188. - DOI - PubMed

MeSH terms

LinkOut - more resources